Priority-driven research

Overview

Cancer Australia has developed the Priority-driven Collaborative Cancer Research Scheme to support research that reduces the impact of cancer on the community and improves outcomes for people affected by cancer.

The Priority-driven Collaborative Cancer Research Scheme is an innovative research funding scheme which brings together government and other funders of cancer research to collaboratively fund cancer research in Australia. These partnerships help:

better coordinate funding of priority-driven cancer research,
fund research which can impact on practice and policy and improve outcomes,
foster collaboration between cancer researchers to build Australia’s cancer research capacity, and
foster consumer participation in cancer research, from design to implementation.

Working with the National Health and Medical Research Council (NHMRC)

This research scheme is managed by Cancer Australia and the agency works in collaboration with the NHMRC in this grant scheme. The NHMRC facilitates registration and initial assessment of applications, and will endorse grants funded through this scheme.

The NHMRC and Cancer Australia have prepared a joint statement highlighting how research supported through the Priority-driven Collaborative Cancer Research Scheme complements cancer research activities funded by the NHMRC.

National Health and Medical Research Council and Cancer Australia (PDF 196KB)

Successful applicants for 2011 Round

On 9 December 2011, the Australian Government announced the successful applicants for the 2011 Round of the Priority-driven Collaborative Cancer Research Scheme proudly funded by Cancer Australia, Cure Cancer Australia Foundation, Leukaemia Foundation, National Breast Cancer Foundation, Prostate Cancer Foundation of Australia, Cancer Council Australia, Cancer Council NSW and beyondblue: the national depression and anxiety initiative.